DMT
-
healthPsychedelics Share Common Brain 'Fingerprint,' Study Reveals
A groundbreaking study identifies a shared neural signature across five psychedelics, offering new insights into their therapeutic potential for mental health disorders.
-
healthScientists Engineer Tobacco Plant to Produce 5 Psychedelic Compounds Simultaneously
Researchers at the Weizmann Institute have engineered a tobacco plant to produce five psychedelic compounds, offering a new avenue for therapeutic research and production.
-
healthDMT Shows Dramatic Depression Symptom Reduction in New Trial
A single dose of the psychedelic DMT significantly reduced major depressive disorder symptoms in a recent Phase IIa trial, offering hope for rapid-acting treatments.
-
healthPsychedelic Compound Shows Promise in Cutting Depression Symptoms
A clinical study reveals that a single dose of DMT, a naturally occurring psychedelic, significantly reduced depression symptoms in participants.
-
healthDMT Shows Antidepressant Promise in Small Clinical Trial
A small clinical trial suggests the hallucinogen DMT may be an effective antidepressant, offering hope for new treatment options.
-
healthAyahuasca Compound Shows Promise in Easing Depression
New research suggests a single dose of DMT, the active compound in ayahuasca, could significantly reduce depressive symptoms, offering a potential new avenue for treatment.